DECEMBER 19, 2024

Addressing MASLD Risk Factors Can Reduce Risk for Metachronous Colorectal Neoplasms

The increased risk for metachronous colorectal neoplasms after polypectomy in patients with metabolic dysfunction–associated steatotic liver disease can be ameliorated in a dose-dependent manner if metabolic dysfunction is improved, according to the results of a large study from Taiwan.

“Interventions for reducing metabolic dysfunction during the surveillance interval can be regarded as a strategy of primary prevention against metachronous [colorectal] neoplasms in MASLD